465 related articles for article (PubMed ID: 10916099)
1. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
John MR; Goodman WG; Gao P; Cantor TL; Salusky IB; Jüppner H
J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
6. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
[TBL] [Abstract][Full Text] [Related]
7. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
Lewin E; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
Silverberg SJ; Gao P; Brown I; LoGerfo P; Cantor TL; Bilezikian JP
J Clin Endocrinol Metab; 2003 Oct; 88(10):4725-30. PubMed ID: 14557447
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
[TBL] [Abstract][Full Text] [Related]
11. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
Brandi L; Egfjord M; Olgaard K
Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
[TBL] [Abstract][Full Text] [Related]
12. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples.
Lepage R; Roy L; Brossard JH; Rousseau L; Dorais C; Lazure C; D'Amour P
Clin Chem; 1998 Apr; 44(4):805-9. PubMed ID: 9554492
[TBL] [Abstract][Full Text] [Related]
13. Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
Kawata T; Imanishi Y; Kobayashi K; Onoda N; Takemoto Y; Tahara H; Okuno S; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
J Clin Endocrinol Metab; 2005 Oct; 90(10):5774-8. PubMed ID: 16046589
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
Hackeng WH; Lips P; Netelenbos JC; Lips CJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism.
Togashi K; Takahashi N; Ando K; Tsukamoto Y; Marumo F
Int J Artif Organs; 1990 Feb; 13(2):77-82. PubMed ID: 2347659
[TBL] [Abstract][Full Text] [Related]
16. Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radio-immunoassay.
Frölich M; Walma ST; Paulson C; Papapoulos SE
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():69-72. PubMed ID: 2310159
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.
Solal ME; Sebert JL; Boudailliez B; Marie A; Moriniere P; Gueris J; Bouillon R; Fournier A
J Clin Endocrinol Metab; 1991 Sep; 73(3):516-24. PubMed ID: 1874930
[TBL] [Abstract][Full Text] [Related]
18. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.
Quarles LD; Lobaugh B; Murphy G
J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
20. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
